J9025 HCPCS code: Injection, azacitidine, 1 mg
J9025 is the HCPCS Level II code for injection, azacitidine, 1 mg. In 2024 Medicare paid an average of $0.29 per service for J9025 across 16,562,232 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume fell 5% from 2022 to 2024 (17,357,323 to 16,562,232 services). In 2024, about 3,548 clinicians billed Medicare for J9025 for 3,496 beneficiaries; Florida, Texas, California accounted for 38% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2006-01-01 |
| Last action effective | 2023-01-01 |
Who bills J9025 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,548 |
| Medicare beneficiaries | 3,496 |
| States with claims | 41 |
| Share of services in top 3 states (Florida, Texas, California) | 38% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9025, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 17,357,323 | 3,651 | $0.69 | $0.55 |
| 2023 | 16,817,381 | 3,574 | $0.43 | $0.34 |
| 2024 | 16,562,232 | 3,496 | $0.37 | $0.29 |
States with the most J9025 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 2,693,715 | $0.29 |
| Texas | 1,980,839 | $0.30 |
| California | 1,488,475 | $0.29 |
| Virginia | 922,675 | $0.29 |
| Illinois | 870,978 | $0.30 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J9025
- 2006-01-01: J9025 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9025?
J9025 is the HCPCS Level II code for injection, azacitidine, 1 mg. Short descriptor: "Azacitidine injection".
How much does Medicare pay for J9025?
In 2024, the average Medicare payment was $0.29 per service (average allowed $0.37).
Does Medicare cover J9025?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9025 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9003 — Leuprolide injectable (camcevi etm), 1 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9025
- Watch J9025 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9025
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.